PROTHENA CORP PLC

Profile

Company Names

PROTHENA CORP PLC

Addresses

ADELPHI PLAZA, UPPER GEORGE-S STREET, DUN LAOGHAIRE, CO. DUBLIN, L2 A96 T927

Phone Numbers

011-353-1-236-2500

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

IRELAND

Total Amount Raised:

$49,999,997.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2018-03-21 
$49,999,997.00 
$49,999,997.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
RICHARD 
T. 
COLLIER 
DIRECTOR
PROTHENA CORP PLC
SHANE 
M. 
COOKE 
DIRECTOR
PROTHENA CORP PLC
LARS 
G. 
ECKMAN, M.D., PH.D. 
DIRECTOR
PROTHENA CORP PLC
ANDERS 
O. 
HARFSTRAND, M.D., PH.D. 
DIRECTOR
PROTHENA CORP PLC
CHRISTOPHER 
S. 
HENNEY, PH.D., D.SC. 
DIRECTOR
PROTHENA CORP PLC
ARTHUR 
W. 
HOMAN 
EXECUTIVE OFFICER
PROTHENA CORP PLC
CAROL 
D. 
KARP 
EXECUTIVE OFFICER
PROTHENA CORP PLC
GENE 
G. 
KINNEY, PH.D. 
EXECUTIVE OFFICER, DIRECTOR
PROTHENA CORP PLC
TRAN 
B. 
NGUYEN 
EXECUTIVE OFFICER
PROTHENA CORP PLC
TARA 
 
NICKERSON, PH.D. 
EXECUTIVE OFFICER
PROTHENA CORP PLC
DENNIS 
J. 
SELKOE 
DIRECTOR
PROTHENA CORP PLC
KARIN 
L. 
WALKER 
EXECUTIVE OFFICER
PROTHENA CORP PLC   |  CYCLACEL PHARMACEUTICALS, INC.
WAGNER 
M. 
ZAGO, PH.D. 
EXECUTIVE OFFICER
PROTHENA CORP PLC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2018-03-29
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2018-03-21 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
N/A
NONE